Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2005
08/31/2005CN1661096A Nucleic acid detecting cassette, nucleic and detecting apparatus utilizing nucleic acid detecting cassette, and nucleic acid detecting system utilizing nucleic acid detecting cassette
08/31/2005CN1661089A Biology method for detecting dioxin in trace quantity
08/31/2005CN1661088A Fluorescence quantitative PCR kit for detecting virus of aftosa and application
08/31/2005CN1661087A Detecting unit for detecting hybridization and other interactions and DNA chip and other bioassay substrates having the detecting unit
08/31/2005CN1661085A Relativity between gene of transfer protein of cholesterol ester and essential hypertension
08/31/2005CN1661084A Relativity between transfer protein gene of cholesterol ester and essential hypertension
08/31/2005CN1661083A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661082A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661081A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661080A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661079A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661078A Relativity between converzyme gene of angiotensing I and essential hypertension
08/31/2005CN1661077A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661076A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661075A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661074A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661073A Relativity between gene of catalase and essential hypertension
08/31/2005CN1661072A Relativity between gene 1A of arginine-vasopressin receptor and essential hypertension
08/31/2005CN1661071A Relativity between C2 gene of apolipoprotein and essential hypertension
08/31/2005CN1661070A Relativityl between converzyme gene of angiotensin I and essential hypertension
08/31/2005CN1661069A Relativity between gene of angiotensin I converting enzyme and essential hypertension
08/31/2005CN1661068A Relativity between gene SNP of insulin receptor and essential hypertension
08/31/2005CN1661067A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661066A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661065A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661064A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661063A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661062A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661061A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661059A Relativity between SNP gene of insulin receptor and essential hypertension
08/31/2005CN1661058A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661057A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661056A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661055A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661054A Relativity between gene of haptoglobin and essential hypertension
08/31/2005CN1661053A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661052A Relativity between gene of endothelin 1 and essential hypertension
08/31/2005CN1661051A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661050A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661049A Relativity between gene of growth hormone 1 and essential hypertension
08/31/2005CN1661048A Relativity between proto-oncogene of leukaemia in myeloblast class essential hypertension
08/31/2005CN1661047A Relativity between proto-oncogene of leukaemia in myeloblast class and essential hypertension
08/31/2005CN1661046A Relativity between synthetase of endothelium-nitrogen oxide and essential hypertension
08/31/2005CN1661045A Relativity between proto-oncogene of leukaemia in myeloblast class and essential hypertension
08/31/2005CN1661042A Method for screening out medication of anti tumours with HIF as target point and application
08/31/2005CN1661039A Method for preparing chips of cell and equipment
08/31/2005CN1660961A Method for preparing biological functional water-soluble quantum point of sugar
08/31/2005CN1660960A Method for preparing water-soluble quantum point of biological functionalized sugar
08/31/2005CN1660913A Immunoassays for anti-HCV antibodies
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660907A Monoclonal antibody of anti lymphocyst virus of and preparation method
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660893A Section of synthesized peptide S28-42 of troponin I of human cardiac muscle and application
08/31/2005CN1660890A Method of anticipating interaction between proteins
08/31/2005CN1660380A Method for preparing liangfuwan and method for controlling quality
08/31/2005CN1660379A Combination of medication, preparing method and method of controlling quality
08/31/2005CN1660014A Blood sugar level measuring apparatus
08/31/2005CN1660013A Blood sugar level measuring apparatus
08/31/2005CN1660012A Blood sugar level measuring apparatus
08/31/2005CN1217194C Protein chip and its preparing process and application
08/31/2005CN1217193C Luminol chemiluminescence immunological analysis detecting method for cardiac muscle calcium protein
08/31/2005CN1217192C Photoelectrochemical tag, method, instrument and kit for photoelectrochemical analysis
08/31/2005CN1217191C Homologous system model method for quantitatively detecting bacterial endotoxin of blood
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1217189C Method for quantitating leukocyte count in whole blood sample
08/31/2005CN1217179C Spectroscopic method for measuring isotope gas 13 Co2/12Co2 in human body
08/31/2005CN1217152C Device and method for identifying metal body
08/31/2005CN1217009C Process for producing hydrogel biochip by using epoxy-contained radial polyethylene glycol derivative
08/31/2005CN1217007C Assay for measurement of DNA synthesis rates
08/31/2005CN1217003C Micro array reaction apparatus and uses thereof
08/31/2005CN1216995C DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses
08/31/2005CN1216910C Novel liver regeneration related protein, its code sequence and application
08/31/2005CN1216902C Specific protein of SARS virus, clinical detection method and kit
08/31/2005CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease
08/30/2005US6937939 Soil measuring instrument, soil measurement assisting device and method, recorded medium on which a program is recorded, recorded medium on which data is recorded, application amount controller, application amount determining device, method for them, and farm working determination assisting system
08/30/2005US6936834 Method and apparatus for determining stone cells in paper or pulp
08/30/2005US6936829 Image read-out method and apparatus
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936702 Charge-switch nucleotides
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936687 Compositions for the detection of enzyme activity in biological samples and methods of use thereof
08/30/2005US6936617 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
08/30/2005US6936477 Complex combinatorial chemical libraries encoded with tags
08/30/2005US6936476 Point of care diagnostic systems
08/30/2005US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET)
08/30/2005US6936473 Method of preparing a biological sample for quantification
08/30/2005US6936462 High throughput screen
08/30/2005US6936461 Method for immobilizing multistranded nucleic acid molecules by modifying more than one strand thereof, and binding each strand to a solid support
08/30/2005US6936453 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
08/30/2005US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
08/30/2005US6936442 Amplification; genetic engineering
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005US6936430 detecting coagulation abnormalities in a plasma sample by determining a test rate of thrombin generation over a given time interval by reacting activator of thrombin with defibrinated normal plasma in presence of defibrinated test plasma sample
08/30/2005US6936429 Ligand based solution assay for low concentration analytes
08/30/2005US6936427 Real time detection of intermolecular interaction
08/30/2005US6936424 Materials and methods for detection and treatment of breast cancer
08/30/2005US6936423 Anti-LTNF for in vitro assay of biological toxins
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936259 For therapy and prophylaxis of bacterial infections